Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biotech Fluidics AB
AB
Active
Org 5567269278
Råövägen 300, 439 92
Onsala
Manufacture of optical instruments, magnetic and optical media and photographic equipment
·
NACE 2670
Est. 2007 · 19 years old
13 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of optical instruments, magnetic and optical media and photographic equipment
/
Biotech Fluidics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
133M
100M
67M
33M
0M
2021: 70M
70M
2021
2022: 101M (+44% vs 2021)
101M
+44%
2022
2023: 107M (+6% vs 2022)
107M
+6%
2023
2024: 74M (-31% vs 2023)
74M
-31%
2024
2025: 79M (+7% vs 2024)
79M
+7%
2025
EBITDA
SEK millions
17M
13M
9M
4M
0M
2021: 7M
7M
2021
2022: 14M (+100% vs 2021)
14M
+100%
2022
2023: 11M (-21% vs 2022)
11M
-21%
2023
2024: 6M (-45% vs 2023)
6M
-45%
2024
2025: 11M (+83% vs 2024)
11M
+83%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
78 509
73 666
106 508
101 205
70 375
Staff expenses
−11 461
−14 113
−13 345
—
—
EBITDA
11 135
5 650
11 040
13 622
6 870
Depreciation & amort.
−32
−29
−23
−25
−56
EBIT
11 104
5 620
11 017
13 597
6 814
Net financials
273
1 700
1 136
1 039
3 434
Profit before tax
9 309
6 560
9 594
13 637
8 348
Tax
−1 958
−1 443
−2 037
−2 868
−1 190
Net profit
7 351
5 117
7 557
10 769
7 158
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
51 165
45 583
47 637
45 902
29 893
Equity
31 848
27 997
26 780
23 054
14 784
Long-term debt
—
—
—
0
0
Short-term debt
6 642
7 111
11 142
15 723
8 984
Total debt
6 642
7 111
11 142
15 723
8 984
Financial ratios
5-year trend
EBITDA margin
14,2 %
This company
15,8 %
Market median
This company
Market median
10% below market
2021
2025
Equity ratio
62,2 %
This company
38,2 %
Market median
This company
Market median
63% above market
2021
2025
Return on equity
23,1 %
This company
18,4 %
Market median
This company
Market median
26% above market
2021
2025
Net profit margin
9,4 %
This company
8,1 %
Market median
This company
Market median
16% above market
2021
2025
Asset turnover
1,53×
This company
1,12×
Market median
This company
Market median
37% above market
2021
2025
Debt / equity
0,61×
This company
0,62×
Market median
This company
Market median
2% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biotech Fluidics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
